Costanza Alciati, a pharma analyst at GlobalData, told BioSpace in an email that GLP-1s will definitely dominate the market in the near future, but new entrants into the space are already looking for the next drug class that could revolutionize the space. Companies taking an alternative approach are forecast to capture only a very small portion of the obesity marketroughly 6.3%across the seven major markets (U.S., France, Germany, Italy, Spain, UK and Japan) by the end of 2031, according to Sara Reci, a senior analyst at GlobalData
It's already a somewhat longer process for me every morning
Federal Drug Regulatory Authority of United States warns against use of intravenous glutathione for whitening or lightening treatments
Infused with GHK-Cu peptides, this body wash promotes collagen production, firms the skin, improves hydration, and supports a smoother texture for daily skin rejuvenation